The tumour necrosis factor alpha -238 G → A and -308 G → A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young healthy relatives of Type II diabetic patients

Diabetologia

Volumn 43, Issue 2, 2000, Pages 181-184

  Koch, M ^a,b   Rett, K ^a   Volk, A ^a   Maerker, E ^a   Haist, K ^a   Weisser, M ^a   Rettig, A ^a   Renn, W ^a   Haring H U ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Labor Wagner und Partner   (Germany)

Author keywords

First degree relatives; Insulin resistance; Promotor polymorphisms; Tumour necrosis factor ; Type II diabetes

Indexed keywords

AMINO ACID; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ANTHROPOMETRY; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; DNA POLYMORPHISM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SENSITIVITY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0034000115     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050027     Document Type: Article

References (10)

1. 1. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR (1990) Slow glucose removal rate and hyperinsulinemia precede the development of Type II diabetes in the offspring of diabetic parents. Ann Intern Med 113: 909-915
2. 2. Hotamisligil GS, Spiegelman BM (1994) Tumour necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43: 1271-1278
3. 3. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A (1993) Tumour necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268: 26055-26058
4. 4. Day CP, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M (1998) Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia 41: 430-434
5. 5. Wilson AG, Di Giovine FS, Blakemore AI, Duff GW (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1: 353
6. 6. Hamann A, Mantzoros C, Vidal Puig A, Flier JS (1995) Genetic variability in the TNF-alpha promoter is not associated with Type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 211: 833-839
7. 7. Wilson AG, Symons JA, McDowell TL, McDevitt HO (1997) Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 94: 3195-3199
8. 8. Kellerer M, Rett K, Renn W, Groop L, Haring HU (1996) Circulating TNF-alpha and leptin levels in offspring of NIDDM patients do not correlate to individual insulin sensitivity. Horm Metab Res 28: 737-743
9. 9. Fernandez-Real JM, Gutierrez C, Ricart W et al. (1997) The TNF-alpha gene NcoI polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 46: 1468-1472
10. 10. Winkler G, Salamon F, Salamon D, Speer G, Simon K, Cseh K (1998) Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in Type II (non-insulin-dependent) diabetes and in obesity. Diabetologia 41: 860-861